Global Cardiac PoC Testing Devices Market Size study & Forecast, by Product Type (Cardiac Markers Test, Analyzers), by End-Users (Hospitals, Diagnostic Laboratories and Other End-Users), and Regional Analysis, 2022-2029

Global Cardiac PoC Testing Devices Market Size study & Forecast, by Product Type (Cardiac Markers Test, Analyzers), by End-Users (Hospitals, Diagnostic Laboratories and Other End-Users), and Regional Analysis, 2022-2029

Global Cardiac PoC Testing Devices Market is valued at approximately USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XXX% over the forecast period 2022-2029. Cardiac POC testing devices are devices that help in assessing and analyzing the cholesterol and blood glucose levels in the body. The Cardiac PoC Testing Devices market is expanding because of factors such as increasing prevalence of cardiovascular diseases and rising geriatric population.
For instance: According to the World Health Organization, the proportion of the world’s population over and above 60 years went from 12%, in the year 2015 to 22%, by the year end 2050. Further, rising healthcare expenditure has als paved the way towards the growth of the Cardiac PoC Testing Devices in the market. according to Medical Product Outsourcing, in March 2021, The US healthcare system incurred an estimated USD 40 billion, in the year 2017, fueling ASC growth. In 2018, 5,700 ASCs in the United States completed 23 million procedures and earned USD 35 billion in revenue. However, supply chain disruptions and trading bans in the market may halt markets.

The key regions considered for the Global Cardiac PoC Testing Devices Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the space in terms of revenue, owing to rising prevalence of cardiovascular diseases. According to National Cancer Institute, the number of cancer patients is expected to rise to 29.5 million cases, by the year 2040 from 18.1 million cases, in the year 2018. Whereas, Asia Pacific is expected to grow significantly during the forecast period, owing to lack of physical exercise.

Major market players included in this report are:
Nano-Ditech Corporation
Abbott Laboratories
Acon Laboratories Inc
Alfa Scientific Designs Inc
American Screening Corporation Inc
Beckman Coulter Inc. (Danaher Corporation)
Biomerica Inc.
Bio-Rad Laboratories, Inc.
F. Hoffmann-La Roche AG
LifeSign LLC

Recent Developments in the Market:
In January 2022, MEDLAB Middle East, Abbott (Lake Forest, IL, USA) launched a complete product line of various diagnostic tools and medical devices. The main objective of this launch was to provide point-of-care testing that helps manage patients with COVID-19, diabetes cardiovascular disease, and their comorbidities. With this launch, the company will provide the end-users with a variety of innovative products in the long run.
In January 2022, PocDoc: a digital health platform & personal diagnostics provider launched the smartphone-based test approved mainly for cardiovascular diseases. With this launch, the company will enhance its product portfolio base in the forecast period.
Global Cardiac PoC Testing Devices Market Report Scope:
Historical DataCompanies Mentioned

Nano-Ditech Corporation
Abbott Laboratories
Acon Laboratories Inc
Alfa Scientific Designs Inc
American Screening Corporation Inc
Beckman Coulter Inc. (Danaher Corporation)
Biomerica Inc.
Bio-Rad Laboratories, Inc.
F. Hoffmann-La Roche AG
LifeSign LLC

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.